Seek urgent medical attention if you develop jaundice (yellowing of skin/eyes), severe allergic reactions, or persistent gastrointestinal symptoms
Della Pepa G, Patrcio BG, Carli F, et al
In trials of the branded products, tirzepatide produced larger average weight reductions, while semaglutide has the longest track record and, in its branded form, a proven cardiovascular risk-reduction indication
Flushing: Brief warmth across face or chest after injection
Key observation: All dose groups began at 0.5mg with gradual escalation over several weeks before reaching maintenance doses
PubMed laboratory research record [PMID: 31486321] PubMed record related to this compound for laboratory literature review